Observational studyBritish journal of cancer2018

Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).

Benjamin Daniels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.